BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25872143)

  • 1. High insulin levels in KK-Ay diabetic mice cause increased cortical bone mass and impaired trabecular micro-structure.
    Fu C; Zhang X; Ye F; Yang J
    Int J Mol Sci; 2015 Apr; 16(4):8213-26. PubMed ID: 25872143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of bone fragility by pulsed electromagnetic fields in type 2 diabetic KK-Ay mice involving Wnt/β-catenin signaling.
    Shao X; Yang Y; Tan Z; Ding Y; Luo E; Jing D; Cai J
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E951-E966. PubMed ID: 33719588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and Skeletal Characterization of the KK/A
    Chowdhury NN; Surowiec RK; Kohler RK; Reul ON; Segvich DM; Wallace JM
    Calcif Tissue Int; 2024 Jun; 114(6):638-649. PubMed ID: 38642089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JiangTang XiaoKe granule attenuates cathepsin K expression and improves IGF-1 expression in the bone of high fat diet induced KK-Ay diabetic mice.
    Guo Y; Wang L; Ma R; Mu Q; Yu N; Zhang Y; Tang Y; Li Y; Jiang G; Zhao D; Mo F; Gao S; Yang M; Kan F; Ma Q; Fu M; Zhang D
    Life Sci; 2016 Mar; 148():24-30. PubMed ID: 26892148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function.
    Hamann C; Goettsch C; Mettelsiefen J; Henkenjohann V; Rauner M; Hempel U; Bernhardt R; Fratzl-Zelman N; Roschger P; Rammelt S; Günther KP; Hofbauer LC
    Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1220-8. PubMed ID: 21900121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Tissue Collagen Maturity and Mineral Content Increase With Sustained Hyperglycemia in the KK-Ay Murine Model of Type 2 Diabetes.
    Hunt HB; Pearl JC; Diaz DR; King KB; Donnelly E
    J Bone Miner Res; 2018 May; 33(5):921-929. PubMed ID: 29281127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between insulin use and volumetric bone mineral density, bone micro-architecture and bone strength of the distal radius in patients with type 2 diabetes - The Maastricht study.
    de Waard EAC; Driessen JHM; de Jong JJA; van Geel TACM; Henry RMA; van Onzenoort HAW; Schram MT; Dagnelie PC; van der Kallen CJ; Sep SJS; Stehouwer CDA; Schaper NC; Koster A; Savelberg HHCM; Neef C; Geusens PPMM; de Vries F; van den Bergh JPW
    Bone; 2017 Aug; 101():156-161. PubMed ID: 28487133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalk.
    Adil M; Mansoori MN; Singh D; Kandhare AD; Sharma M
    Biomed Pharmacother; 2017 Oct; 94():1010-1019. PubMed ID: 28810524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of amount of physical activity with cortical bone size and trabecular volumetric BMD in young adult men: the GOOD study.
    Lorentzon M; Mellström D; Ohlsson C
    J Bone Miner Res; 2005 Nov; 20(11):1936-43. PubMed ID: 16234966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
    Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
    Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic bladder dysfunction in T2D KK-Ay mice and its changes in the level of relevant gene expression.
    Zhang J; Zhang Y; Yang X; Wang J; Xu Y; Wang R; Tan B; Huang P; Cao H
    Biomed Pharmacother; 2020 Nov; 131():110706. PubMed ID: 33152907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density averaged over a region of interest on femur is affected by age-related change of bone geometry.
    Luo Y
    Osteoporos Int; 2018 Jun; 29(6):1419-1425. PubMed ID: 29508039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus.
    Pereira M; Gohin S; Lund N; Hvid A; Smitham PJ; Oddy MJ; Reichert I; Farlay D; Roux JP; Cleasby ME; Chenu C
    Osteoporos Int; 2017 Jan; 28(1):309-320. PubMed ID: 27468901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo.
    Syberg S; Brandao-Burch A; Patel JJ; Hajjawi M; Arnett TR; Schwarz P; Jorgensen NR; Orriss IR
    J Bone Miner Res; 2012 Nov; 27(11):2373-86. PubMed ID: 22714653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
    Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
    Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisolone treatment reduces the osteogenic effects of loading in mice.
    Bergström I; Isaksson H; Koskela A; Tuukkanen J; Ohlsson C; Andersson G; Windahl SH
    Bone; 2018 Jul; 112():10-18. PubMed ID: 29635039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-diabetic effects of globin digest and its active ingredient Leu-Ser-Glu-Leu in ICR mice, streptozotocin-induced diabetic mice and KK-Ay mice.
    Nakaoka F; Sasakawa Y; Yamamoto K; Nakao M; Nakamura M; Tong C; Fukuhama C; Kagawa K
    Life Sci; 2010 Mar; 86(11-12):424-34. PubMed ID: 20109472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects on type 2 diabetes mellitus mouse femoral bone achieved by anti-osteoporosis exercise interventions.
    Zhang M; Li Y; Liu L; Huang M; Wang M; Zou J
    Front Endocrinol (Lausanne); 2022; 13():914872. PubMed ID: 36465647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of pathology and pharmacology of diabetic encephalopathy with KK-Ay mouse model.
    Shi S; Yin HJ; Li J; Wang L; Wang WP; Wang XL
    CNS Neurosci Ther; 2020 Mar; 26(3):332-342. PubMed ID: 31401815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone microstructure in healthy men measured by HR-pQCT: Age-related changes and their relationships with DXA parameters and biochemical markers.
    Doi M; Chiba K; Okazaki N; Kondo C; Yamada S; Yokota K; Yonekura A; Tomita M; Osaki M
    Bone; 2022 Jan; 154():116252. PubMed ID: 34743043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.